This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
thetranscendedman
atranscendedman.bsky.social
did:plc:qwvym2ap4kzgfpyih5mjmnbx
In the UK, researchers tested a targeted PD-1 agonist that binds to pancreatic beta cells and found it powerfully inhibits PD-1+ NK cells, reducing inflammation and protecting insulin-producing cells
This may offer new hope for treating type 1 diabetes
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1640509/full
2025-09-09T16:12:38.610Z